In the open-label trial Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive…
Read More
Obsessive-compulsive disorder (OCD) is a pretty common mental health issue affecting about 1-2% of people…
Read More
© 2023-2025. AVYIA Health. All rights reserved.